Skip to main content
Figure 1 | Arthritis Res Ther

Figure 1

From: Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study

Figure 1

Clinical effects of low-dose infliximab therapy (3 mg/kg). Shown are the Disease Activity Score (DAS 30; see Materials and Methods) scores and Psoriasis Area and Severity Index (PASI) scores. Results represent reductions from baseline, shown as mean ± standard error of the mean. Arrows represent infliximab infusions. *P ≤ 0.02 versus baseline.

Back to article page